You are here
- Home
- Therapy Areas
- Neuroscience
Trial of potentiation of antidepressive treatment in refractory depression: A comparison of Seroquel and Lithium.
- Disease
- schizophrenia
- Drug Name
- Seroquel
- Generic Name
- quetiapine
- Sponsor
- AstraZeneca
- Drug Status
- Approved Medicine
- Phase
- IIIb
- Start Date
- May 9, 2002
- Study Name
- 5077/9003
- Study Id
- 5077/9003
- Recruiting Status
- Closed
- Protocol Status
- Not Available
- Report Status
- Not Available
